Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Clofibrate - Inositol Nicotinate
2. Clofibrate, Inositol Nicotinate Drug Combination
3. Liporeduct
1. 57456-45-8
2. 2-(4-chlorophenoxy)-2-methylpropanoic Acid;[2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] Pyridine-3-carboxylate
3. Clofibrate - Inositol Hexanicotinate Mixture
4. Inositol Hexanicotinate - Clofibrate Mixture
5. Clofibrate Mixture With Inositol Hexanicotinate
6. Clofibrate - Inositol Nicotinate
7. Clofibrate, Inositol Nicotinate Drug Combination
8. Myo-inositol, Hexa-3-pyridinecarboxylate, Mixt. With 2-(4-chlorophenoxy)-2-methylpropanoic Acid
| Molecular Weight | 1025.4 g/mol |
|---|---|
| Molecular Formula | C52H41ClN6O15 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 21 |
| Rotatable Bond Count | 21 |
| Exact Mass | 1024.2318423 g/mol |
| Monoisotopic Mass | 1024.2318423 g/mol |
| Topological Polar Surface Area | 282 Ų |
| Heavy Atom Count | 74 |
| Formal Charge | 0 |
| Complexity | 1420 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Liporeduct Forte manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Liporeduct Forte, including repackagers and relabelers. The FDA regulates Liporeduct Forte manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Liporeduct Forte API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Liporeduct Forte supplier is an individual or a company that provides Liporeduct Forte active pharmaceutical ingredient (API) or Liporeduct Forte finished formulations upon request. The Liporeduct Forte suppliers may include Liporeduct Forte API manufacturers, exporters, distributors and traders.
Liporeduct Forte Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Liporeduct Forte GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Liporeduct Forte GMP manufacturer or Liporeduct Forte GMP API supplier for your needs.
A Liporeduct Forte CoA (Certificate of Analysis) is a formal document that attests to Liporeduct Forte's compliance with Liporeduct Forte specifications and serves as a tool for batch-level quality control.
Liporeduct Forte CoA mostly includes findings from lab analyses of a specific batch. For each Liporeduct Forte CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Liporeduct Forte may be tested according to a variety of international standards, such as European Pharmacopoeia (Liporeduct Forte EP), Liporeduct Forte JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Liporeduct Forte USP).
LOOKING FOR A SUPPLIER?
